Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
KEY PUBLICATIONS IN RECURRENT/METASTATIC HEAD AND NECK CANCERS
Chairpersons :
K Pavithran, Medical Oncologist, Kochi Govind Babu, Medical Oncologist, Bangalore P K Julka, Radiation Onclogist, Delhi
Speaker :
Rakesh Pinninti